Kathleen Clarence-Smith

Founder at

Km Pharmaceutical Consulting LLC

79 year

72 connections

Health Technology

Finance

Consumer Services

Profile

Kathleen E.
Clarence-Smith was the founder of Prestwick Scientific Capital, Inc. founded in 1996, OXIS Biotech, Inc. founded in 2014, Georgetown Translational Pharmaceuticals, Inc. founded in 2015, and Chase Pharmaceuticals Corp.
founded in 2007 where the title of Chief Medical Officer was held from 2014 to 2016.
Dr. Clarence-Smith is also the founder of Prestwick Chemical, Inc.,Prestwick Pharmaceuticals, Inc.,Km Pharmaceutical Consulting LLC..
Dr. Clarence-Smith currently holds the position of Director at Riverside Pharmaceuticals Corp., Westhaven Therapeutics Corp., and DAS Therapeutics, Inc. Dr. Clarence-Smith is a Member of the American Academy of Neurology since 1990.
Former positions include Vice Chairman & President-Neurology Division at GT Biopharma, Inc. from 2018 to 2018, Senior Director-CNS Clinical Development at Hoffmann-La Roche, Inc., Director at Chase Therapeutics Corp., Research Analyst at Stanford Group Co., and Head-CNS Group at Sanofi from 1987 to 1987.
Education includes a doctorate from Université François-Rabelais de Tours.

Kathleen Clarence-Smith active positions

Companies	Position	Start
Km Pharmaceutical Consulting LLC Km Pharmaceutical Consulting LLC Km Pharmaceutical Consulting LLC is a specialized consulting and project management firm serving the pharmaceutical industry. The private company is based in Washington, DC. The company provides strategic consulting and regulatory services throughout drug development, including clinical and non-clinical program management, FDA regulatory interactions, and patent and licensing strategies. It supports clients with early strategic planning, oversight, and customized team assembly, particularly assisting non-US companies and biotech firms lacking US-based resources. The company’s expertise includes clinical trial design and management, regulatory submissions, development plan formulation, safety and efficacy data interpretation, and due diligence. The company was founded by Kathleen E. Clarence-Smith.	Founder	-
American Academy of Neurology American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists	Corporate Officer/Principal	01/01/1990
Riverside Pharmaceuticals Corp. Riverside Pharmaceuticals Corp. MiscellaneousMiscellaneous Operates as a non-classified establishment	Director/Board Member	-
Westhaven Therapeutics Corp.	Director/Board Member	-
DAS Therapeutics, Inc. DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company	Director/Board Member	-

All active positions of Kathleen Clarence-Smith

Former positions of Kathleen Clarence-Smith

Companies	Position	End
GT BIOPHARMA, INC.	Chief Executive Officer	-
Chase Pharmaceuticals Corp. Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease	Founder	01/01/2016
Stanford Group Co. Stanford Group Co. Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	01/02/2009
SANOFI	Corporate Officer/Principal	01/01/1987
░░░░░ ░░░░░░░░░░░░ ░░░░░	░░░░░░░░	-

See the detail of Kathleen Clarence-Smith's experience

Training of Kathleen Clarence-Smith

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kathleen Clarence-Smith's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
GT Biopharma, Inc. GT Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovering, developing and commercializing novel therapeutics	Health Technology
Stanford Group Co. Stanford Group Co. Investment Banks/BrokersFinance Provides brokerage services	Finance
Sanofi Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines	Health Technology
Prestwick Pharmaceuticals, Inc. Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system	Health Technology
Chase Pharmaceuticals Corp. Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease	Health Technology
Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions	Health Technology
Université François-Rabelais de Tours Université François-Rabelais de Tours Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
American Academy of Neurology American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists	Commercial Services
Km Pharmaceutical Consulting LLC Km Pharmaceutical Consulting LLC Km Pharmaceutical Consulting LLC is a specialized consulting and project management firm serving the pharmaceutical industry. The private company is based in Washington, DC. The company provides strategic consulting and regulatory services throughout drug development, including clinical and non-clinical program management, FDA regulatory interactions, and patent and licensing strategies. It supports clients with early strategic planning, oversight, and customized team assembly, particularly assisting non-US companies and biotech firms lacking US-based resources. The company’s expertise includes clinical trial design and management, regulatory submissions, development plan formulation, safety and efficacy data interpretation, and due diligence. The company was founded by Kathleen E. Clarence-Smith.
Prestwick Scientific Capital, Inc.
Prestwick Chemical, Inc. Prestwick Chemical, Inc. Pharmaceuticals: OtherHealth Technology Founded in 1999, Prestwick Chemical, Inc. specializes in providing diverse, high-quality chemical libraries to support drug discovery and biomedical research worldwide. The private company is based in Washington, DC. The company's flagship Prestwick Chemical Library® comprises 1,760 mainly FDA-approved, off-patent small-molecule drugs designed to accelerate early drug discovery. The company offers multiple specialized libraries tailored to specific research needs, including a GPCR drug library, an OnCombo library for identifying synergistic anticancer drug combinations, a peptidic macrocycle library for medicinal chemistry applications, and a C. elegans library for chemical diversity and tolerability studies. All libraries emphasize chemical and pharmacological diversity, high purity, stability, and are accompanied by comprehensive databases detailing targets, therapeutic classes, side effects, ADMET properties, and other relevant data. Prestwick Chemical also provides compound supply, analog search, hit confirmation, SAR analysis, and custom synthesis services to support flexible R&D solutions.	Health Technology
OXIS Biotech, Inc. OXIS Biotech, Inc. BiotechnologyHealth Technology Develops prodrug therapeutic for the treatment of cancer	Health Technology
Georgetown Translational Pharmaceuticals, Inc. Georgetown Translational Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Provides treatment for neuropathic pain, refractory epilepsies, the symptoms of myasthenia gravis, and motion sickness	Health Services
Chase Therapeutics Corp. Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Engages in developing medications for treating neurodegenerative disorders	Health Technology
Riverside Pharmaceuticals Corp. Riverside Pharmaceuticals Corp. MiscellaneousMiscellaneous Operates as a non-classified establishment	Miscellaneous
Westhaven Therapeutics Corp.
DAS Therapeutics, Inc. DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company	Health Technology